TP53 and breast neoplasm: Our data suggested that activation of p53 signaling by either chemotherapy induced DNA damage or small molecules that prevent p53 degradation decreased cell cycle gene expression resulting in G1/G0 arrest in a subset of breast tumor cell lines harboring WT TP53 alleles.